By David Agrella, Bryan Haas, Pharm.D., Timothy King, Dr.P.H. and Scott Maisto , PPD
Published November 13, 2014
This article discusses the advantages to both biopharmaceutical companies and their vendors of moving outsourcing spend to a commercial model focused on the desired deliverable and not the level of effort required to achieve the deliverable. Read More »
As use of outsourcing increases, more companies see it as strategic, and relationships with service providers as partnerships. However, basic communications, vendor oversight and information transfer remain challenges.
Read More »